Skip to content

Effect of Frax Pro diode laser on rejuvenating periorbital skin

Determinig the efficacy of Frax Pro diode 1550 nm laser therapy on rejuvenating periorbital skin in patients with periorbital darkness and or wirnkles

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230107057072N1
Enrollment
10
Registered
2023-01-21
Start date
2023-03-21
Completion date
Unknown
Last updated
2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rejuvenating periorbital skin.

Interventions

Intervention group: 10 patients above 18 years old of age will be going under 3 treatment sessions of laser therapy with non ablative Frax Pro diode laser, each session devided by one month interval.

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patient with darkness or wrinkles around the eyes Having a written consent Being over 18 years old

Exclusion criteria

Exclusion criteria: The patient's lack of consent to participating in the study The use of anticoagulant drugs or the presence of bleeding diseases in the person Using topical anti-wrinkle or anti-darkening medicine at the same time Freshly tanned skin Pregnant and lactating patients People who take drugs with the possibility of photosensitivity (such as retinoids) People with active infectious lesions of the skin, including herpes, dermatophytosis

Design outcomes

Primary

MeasureTime frame
The percentage of reduction of darkness and wrinkles of the periorbital skin. Timepoint: At the beginning of the study, one month after the first treatment session, one month after the second treatment session, one month after the third treatment session. Method of measurement: Clinical evaluation (obseravation) of two dermatologists.

Secondary

MeasureTime frame
The satisfaction Score of the patient. Timepoint: One month after the first treatment session, one month after the second treatment session, one month after the third treatment session. Method of measurement: Scoring from 1 to 10.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGhazaleh Baghaie Shiva

Tehran University of Medical Sciences

ghazaleh.baghaie@gmail.com+98 11 4442 1518

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026